The use of antibiotics in the production of animal proteins and its consequences
The abuse and misuse of antibiotics in animals and humans are contributing to the increased threat posed by antimicrobial resistance. [...]
Blog
Sergio Lucero: “Amarin differentiates itself by respecting all the rules and being flexible in dealing”
In transdermal pharmaceutical development, the initial instinct of many business development managers is to default to the largest available CDMO, the assumption being that scale correlates with capability, and that a recognized name reduces risk. [...]
Cleaning Validation in Transdermal Patch Manufacturing: GMP Requirements and Best Practices
Cleaning validation in transdermal patch manufacturing is a critical GMP requirement that goes beyond routine equipment cleaning. It is the documented, systematic demonstration that an approved cleaning procedure consistently removes active pharmaceutical ingredient (API) residues — and any other contaminants — to levels that cannot compromise the safety, identity, strength, [...]
Eco-pharmacology: drug contamination
Contamination of drugs raises concern because of the risks that constant exposure to drugs in the environment and in humans can bring. [...]
Dr. Francisco Stefano: “The truth is not always what you believe, but what you find”
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists. [...]
Search for alternative methods for animal experimentation
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products. [...]
Transdermal Patch Adhesion Evaluation Methods: Grid Template vs. Weight Ratio
Correct adhesion of a transdermal patch throughout its entire wear period is not an aesthetic property — it is a drug delivery important condition. A patch that partially lifts off from the skin delivers less drug than labeled, with unpredictable pharmacokinetic consequences [...] [...]
Challenges in the analytical method transfer of transdermal pharmaceutical products
Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, .. [...]
Transdermal Patch Manufacturing: The Three Critical Stages of a GMP Process
Transdermal patch production is a continuous process that demands precision at every stage and accumulated knowledge of the variables involved. It is not a process mastered quickly. Three articulated stages — mixing, coating/drying/laminating, and die-cutting/packaging — define the final outcome: a transdermal drug delivery system that is safe, effective, and [...]
Alzheimer’s Month
On September 21, World Alzheimer's Day is commemorated, in the context of World Alzheimer's Month. [...]